Cardiology 2013

URL: http://www.ncbi.nlm.nih.gov/pubmed/24136775

 

 

Reference Type:  Journal Article

Record Number: 576Author: Chaoui, R. and Gardiner, H.

Year: 2013

Title: Perinatal Cardiology 2013

Journal: Semin Fetal Neonatal Med

Volume: 18

Issue: 5

Pages: 235-6

Date: Oct

Short Title: Perinatal Cardiology 2013

Alternate Journal: Seminars in fetal & neonatal medicine

ISSN: 1878-0946 (Electronic)

1744-165X (Linking)

DOI: 10.1016/j.siny.2013.05.010

Accession Number: 23827389

Notes: Chaoui, R

Gardiner, H

eng

Editorial

Introductory

Netherlands

2013/07/06 06:00

Semin Fetal Neonatal Med. 2013 Oct;18(5):235-6. doi: 10.1016/j.siny.2013.05.010. Epub 2013 Jul 1.

URL: http://www.ncbi.nlm.nih.gov/pubmed/23827389

Author Address: Prenatal Diagnosis & Human Genetics Center, Friedrichstrasse 147, 10117 Berlin, Germany. Electronic address: chaoui@feindiagnostik.de.

 

 

Reference Type:  Journal Article

Record Number: 790Author: Charakida, M., Masi, S. and Deanfield, J. E.

Year: 2013

Title: The Year in Cardiology 2012: focus on cardiovascular disease prevention

Journal: Eur Heart J

Volume: 34

Issue: 4

Pages: 314-7

Date: Jan

Short Title: The Year in Cardiology 2012: focus on cardiovascular disease prevention

Alternate Journal: European heart journal

ISSN: 1522-9645 (Electronic)

0195-668X (Linking)

DOI: 10.1093/eurheartj/ehs429

Accession Number: 23284098

Keywords: Biological Markers/blood

Carbonated Beverages/adverse effects

Cardiovascular Diseases/*prevention & control

Cholesterol, HDL/deficiency

Clinical Trials as Topic

Diagnostic Imaging/methods/trends

Early Diagnosis

Forecasting

Humans

Obesity/complications

Practice Guidelines as Topic

Risk Factors

Abstract: Current data suggest that advances in cardiovascular (CV) treatment have resulted in significant reduction in CV mortality but also in prolongation of life with disability. Focus on CV prevention is likely to reverse this unfavourable trend. In this review we provide information on the new European guidelines on CV prevention and discuss biomarkers and vascular imaging techniques which can assist in refining CV risk prediction. Finally, we provide new information on lifestyle and pharmacological advances which are likely to result in significant CV risk reduction.

Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208